HER2
Clinical trials for HER2 explained in plain language.
Never miss a new study
Get alerted when new HER2 trials appear
Sign up with your email to follow new studies for HER2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ovarian cancer: testing a potentially gentler, targeted treatment
Disease control Recruiting nowThis study is testing a new combination treatment for advanced ovarian cancer. It pairs a standard chemotherapy drug (carboplatin) with a newer, targeted drug called Distamab Vedotin (RC48), which is designed to attack cancer cells with a specific marker (HER2). The goal is to se…
Matched conditions: HER2
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug trial targets Tough-to-Treat HER2 cancers, including brain spread
Disease control Recruiting nowThis is an early-stage study to find a safe and effective dose of a new drug called IAM1363 for people with advanced cancers that have specific changes in a protein called HER2. The trial will enroll about 243 adults whose cancer has worsened after standard treatments, including …
Matched conditions: HER2
Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New cancer drug trial targets specific genetic flaws
Disease control Recruiting nowThis early-stage study is testing a new oral drug called CGT4255 in adults with advanced solid tumors that have specific genetic changes (ERBB2 alterations or HER2 overexpression). The main goals are to find a safe dose and see if the drug can shrink tumors, including those that …
Matched conditions: HER2
Phase: PHASE1 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Italian researchers map rare lung cancer mutation
Knowledge-focused Recruiting nowThis Italian study aims to understand how common HER2 gene mutations are in people with advanced non-small cell lung cancer (NSCLC) and to see how doctors currently diagnose and treat these cases. It will observe about 50 patients over a year to gather this information. The goal …
Matched conditions: HER2
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC